MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia (AML) and other hematologic cancers.

Patient Stabs ED Worker; Campus Building Tied to Cancer; Your Gut and Heart Disease

Note that some links may require registration or subscription. An emergency department worker in Minnesota sustained serious injuries after being stabbed by a 31-year-old patient.

April 4, 2024

Kyverna seeks $182M IPO as biotech runs multiple autoimmune CAR-T trials

Kyverna Therapeutics aims to be the fifth biotech to IPO in 2024 as the autoimmune CAR-T cell therapy maker sets its sights on $182 million

February 2, 2024

Illinois Cannabis Sales Were Flat in November

Illinois adult-use cannabis sales in November were up slightly sequentially to $139.1 million, an increase of 0.3% from October despite one less day. The gain was 6.6%

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.